Days alive and out of hospital for adult female and male cardiac surgery patients: a population-based cohort study

Table 2 Unadjusted changes in days alive and out of hospital at 30- and 90-days for patient factors stratified by patient sex

	DAH₃₀
	Female		Male
	Median	IQR	Median	IQR
Patient factors
CCI ≥ 2	19	10–23	22	16–24
COPD	19	11–23	21	14–24
Diabetes	21	15–24	23	19–25
Peripheral vascular disease	20	12–23	22	16–24
Atrial fibrillation	18	9–22	20	13–23
Stroke/TIA	18	7–23	21	13–24
Chronic liver disease	13	0–21	18	6–23
Chronic kidney disease
Stage 1	23	21–25	24	22–25
Stage 2	22	18–24	23	21–25
Stage 3	19	11–23	21	15–24
Stage 4	13	0–20	16	1–22
Stage 5	13	0–20	17	3–22
Income Quintile
Q1	21	14–24	23	19–25
Q2	22	16–24	23	20–25
Q3	22	16–24	24	20–25
Q4	22	16–24	24	20–25
Q5	22	17–24	24	21–25
Smoking Status
Current	22	16–24	24	20–25
Ex-smoker	22	16–24	23	20–25
Never smoked	22	16–24	23	20–25
Left ventricular ejection fraction
< 20%	19	4–23	20	10–24
20%—34%	19	9–23	22	16–24
35%—49%	21	14–24	23	19–25
≥ 50%	22	17–24	24	21–25
Preoperative ICU	22	16–24	23	20–25
BMI
≤ 25	22	16–24	23	19–25
26–30	22	17–24	24	21–25
≥ 31	22	16–24	23	20–25
Surgeries
Isolated CABG	23	18–24	24	21–25
Single non-CABG
Aortic valve	22	18–24	23	19–25
Mitral valve	22	17–24	23	20–25
Pulmonic/tricuspid	20	4–23	21	13–24
Aneurysectomy/aortic	16	4–21	21	14–24
Combined Surgeries
CABG/valve ± other	19	10–23	21	15–24
Double valve	19	11–22	20	13–23
≥ 3 procedures^a	16	2–21	19	9–22
Other^b	21	15–24	23	17–24

^a ≥ 3 procedures includes triple valve, quadruple valve, double valve with aortic, CABG or aneurysectomy surgery
^b Other includes few combined surgeries of aortic and aneurysectomy, valve and aortic or aneuyrsectomy, CABG and aortic or aneurysectomy surgery
CABG coronary artery bypass grafting, CCI Charlson comorbidity index, COPD chronic obstructive pulmonary disease, DAH days alive and out of hospital

ISSN: 1471-2261